Teladoc Health Statistics
Share Statistics
Teladoc Health has 172.17M shares outstanding. The number of shares has increased by 3.42% in one year.
| Shares Outstanding | 172.17M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.96% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 168.52M |
| Failed to Deliver (FTD) Shares | 1.53K |
| FTD / Avg. Volume | 0.03% |
Short Selling Information
The latest short interest is 26.93M, so 15.64% of the outstanding shares have been sold short.
| Short Interest | 26.93M |
| Short % of Shares Out | 15.64% |
| Short % of Float | 15.98% |
| Short Ratio (days to cover) | 5.58 |
Valuation Ratios
The PE ratio is -15.86 and the forward PE ratio is -11.19.
| PE Ratio | -15.86 |
| Forward PE | -11.19 |
| PS Ratio | 1.34 |
| Forward PS | 0.7 |
| PB Ratio | 1.5 |
| P/FCF Ratio | 18.04 |
| PEG Ratio | n/a |
Enterprise Valuation
Teladoc Health Inc. has an Enterprise Value (EV) of 4.02B.
| EV / Earnings | -18.22 |
| EV / Sales | 1.54 |
| EV / EBITDA | 26.07 |
| EV / EBIT | -16.15 |
| EV / FCF | 20.73 |
Financial Position
The company has a current ratio of 3.54, with a Debt / Equity ratio of 0.66.
| Current Ratio | 3.54 |
| Quick Ratio | 3.47 |
| Debt / Equity | 0.66 |
| Total Debt / Capitalization | 39.81 |
| Cash Flow / Debt | 0.23 |
| Interest Coverage | -11.15 |
Financial Efficiency
Return on equity (ROE) is -0.09% and return on capital (ROIC) is -6.37%.
| Return on Equity (ROE) | -0.09% |
| Return on Assets (ROA) | -0.05% |
| Return on Capital (ROIC) | -6.37% |
| Revenue Per Employee | 540.37K |
| Profits Per Employee | -45.76K |
| Employee Count | 4.82K |
| Asset Turnover | 0.59 |
| Inventory Turnover | 25.75 |
Taxes
| Income Tax | 760.00K |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -49.27% in the last 52 weeks. The beta is 0.9, so Teladoc Health 's price volatility has been higher than the market average.
| Beta | 0.9 |
| 52-Week Price Change | -49.27% |
| 50-Day Moving Average | 9.71 |
| 200-Day Moving Average | 10.59 |
| Relative Strength Index (RSI) | 48.49 |
| Average Volume (20 Days) | 5.70M |
Income Statement
In the last 12 months, Teladoc Health had revenue of $2.60B and earned -$220.37M in profits. Earnings per share was $-1.36.
| Revenue | 2.60B |
| Gross Profit | 1.84B |
| Operating Income | -248.55M |
| Net Income | -220.37M |
| EBITDA | 154.00M |
| EBIT | -248.55M |
| Earnings Per Share (EPS) | -1.36 |
Balance Sheet
The company has $1.12B in cash and $1.59B in debt, giving a net cash position of -$468.60M.
| Cash & Cash Equivalents | 1.12B |
| Total Debt | 1.59B |
| Net Cash | -468.60M |
| Retained Earnings | -15.23B |
| Total Assets | 3.53B |
| Working Capital | 677.25M |
Cash Flow
In the last 12 months, operating cash flow was $350.02M and capital expenditures -$156.35M, giving a free cash flow of $193.67M.
| Operating Cash Flow | 350.02M |
| Capital Expenditures | -156.35M |
| Free Cash Flow | 193.67M |
| FCF Per Share | 1.19 |
Margins
Gross margin is 70.8%, with operating and profit margins of -9.55% and -8.47%.
| Gross Margin | 70.8% |
| Operating Margin | -9.55% |
| Pretax Margin | -8.44% |
| Profit Margin | -8.47% |
| EBITDA Margin | 5.92% |
| EBIT Margin | -9.55% |
| FCF Margin | 7.44% |
Dividends & Yields
TDOC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -13.06% |
| FCF Yield | 10.81% |
Analyst Forecast
The average price target for TDOC is $12, which is 15.3% higher than the current price. The consensus rating is "Hold".
| Price Target | $12 |
| Price Target Difference | 15.3% |
| Analyst Consensus | Hold |
| Analyst Count | 20 |
Scores
| Altman Z-Score | -5.82 |
| Piotroski F-Score | 5 |